Page 2: Ten highlights of the new features in .NET 10.0

Microsoft has released the production-ready versions of .NET 10.0 and Visual Studio 2026. Exciting new features are available ...
pharmaphorum

Two of three trials fail, but Sanofi will still file MS drug

Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...